-
Product Insights
Human Papillomavirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Human Papillomavirus Infections - Drugs In Development, 2023’, provides an overview of the Human Papillomavirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Papillomavirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Genital Warts (Condylomata Acuminata) – Drugs In Development, 2023
Global Markets Direct’s, ‘Genital Warts (Condylomata Acuminata) - Drugs In Development, 2023’, provides an overview of the Genital Warts (Condylomata Acuminata) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Genital Warts (Condylomata Acuminata), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-007 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-007 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TAK-007 in Primary Mediastinal B-Cell Lymphoma Drug Details:TAK-007 is under development...
-
Sector Analysis
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Report Overview HPV is a common virus that can affect different parts of the body. There are several types of HPV, including strains of HPV that cause warts on the hands, feet, and face, and about 30 HPV strains that can affect the genitals. Early detection and treatment of HPV can usually prevent the progression to cancer from happening. The virus remains relatively inactive in early infection but keeps the cell from...